Detalhe da pesquisa
1.
Clinical Epidemiology and Risk Factors for Critical Outcomes Among Vaccinated and Unvaccinated Adults Hospitalized With COVID-19-VISION Network, 10 States, June 2021-March 2023.
Clin Infect Dis
; 78(2): 338-348, 2024 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37633258
2.
Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.
N Engl J Med
; 385(4): 320-329, 2021 07 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34192428
3.
Vaccine Effectiveness Against SARS-CoV-2 Related Hospitalizations in People who had Experienced Homelessness or Incarceration - Findings from the Minnesota EHR Consortium.
J Community Health
; 49(3): 448-457, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38066221
4.
Vaccine Effectiveness Against Influenza-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2021-2022 Season, VISION Network.
J Infect Dis
; 228(2): 185-195, 2023 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36683410
5.
Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19-VISION Network, August 2021 to March 2022.
J Infect Dis
; 227(8): 961-969, 2023 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36415904
6.
Influenza vaccine effectiveness against influenza-A-associated emergency department, urgent care, and hospitalization encounters among U.S. adults, 2022-2023.
J Infect Dis
; 2023 Dec 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38041853
7.
Relationships Between Social Vulnerability and Coronavirus Disease 2019 Vaccination Coverage and Vaccine Effectiveness.
Clin Infect Dis
; 76(9): 1615-1625, 2023 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36611252
8.
Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions - VISION Network, September 2022-April 2023.
MMWR Morb Mortal Wkly Rep
; 72(21): 579-588, 2023 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37227984
9.
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022.
MMWR Morb Mortal Wkly Rep
; 71(53): 1637-1646, 2023 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36921274
10.
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022.
MMWR Morb Mortal Wkly Rep
; 71(5152): 1616-1624, 2022 Dec 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36580430
11.
Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance - VISION Network, 10 States, December 2021-August 2022.
MMWR Morb Mortal Wkly Rep
; 71(42): 1335-1342, 2022 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36264840
12.
Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022.
MMWR Morb Mortal Wkly Rep
; 71(4): 139-145, 2022 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35085224
13.
Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VISION Network, 10 States, December 2021-March 2022.
MMWR Morb Mortal Wkly Rep
; 71(13): 495-502, 2022 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35358170
14.
Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022.
MMWR Morb Mortal Wkly Rep
; 71(7): 255-263, 2022 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35176007
15.
Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years - VISION Network, 10 States, April 2021-January 2022.
MMWR Morb Mortal Wkly Rep
; 71(9): 352-358, 2022 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35239634
16.
Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated - VISION Network, 10 States, December 2021-June 2022.
MMWR Morb Mortal Wkly Rep
; 71(29): 931-939, 2022 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35862287
17.
Association of mRNA Vaccination With Clinical and Virologic Features of COVID-19 Among US Essential and Frontline Workers.
JAMA
; 328(15): 1523-1533, 2022 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36255426
18.
Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19-Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity - Nine States, January-September 2021.
MMWR Morb Mortal Wkly Rep
; 70(44): 1539-1544, 2021 Nov 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34735425
19.
Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults - Nine States, January-September 2021.
MMWR Morb Mortal Wkly Rep
; 70(44): 1553-1559, 2021 Nov 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34735426
20.
Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions - VISION Network, September 2022-April 2023.
Am J Transplant
; 23(7): 1062-1076, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37394267